150864-95-2

Usage

Uses

Used in Organic Synthesis:
1-Ethyl-cyclopropanecarboxylic acid serves as a key building block in organic synthesis, utilized for the creation of various complex organic molecules. Its cyclopropane ring and ethyl group provide a structural foundation that can be further modified to achieve desired chemical properties.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-Ethyl-cyclopropanecarboxylic acid is employed as a precursor in the synthesis of bioactive compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications, contributing to the advancement of medicinal chemistry.
Used in Material Science:
1-Ethyl-cyclopropanecarboxylic acid may also find applications in the development of new materials, leveraging its chemical properties to enhance material performance or introduce novel functionalities.
Used as a Chemical Intermediate in Industrial Processes:
Furthermore, 1-Ethyl-cyclopropanecarboxylic acid functions as a chemical intermediate in a variety of industrial processes, facilitating the production of other chemicals and compounds that are essential across different sectors.

Upstream product

• 1194258-22-4 1,1-dimethylethyl 1-ethylcyclopropanecarboxylate 
• 1447944-39-9 benzyl 1-vinylcyclopropanecarboxylate 
• 664364-37-8 benzyl 1-acetylcyclopropanecarboxylate 
• 130287-75-1 2-tert-pentyl-4,4-dimethyl-4,5-dihydrooxazole 
• 918522-58-4 2-(1-iodo-2-(iodomethyl)butan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole 
• 918522-82-4 2-(1-ethylcyclopropyl)-4,4-dimethyl-4,5-dihydrooxazole 
• 5856-77-9 2,2-dimethylbutanoyl chloride 
• 595-37-9 2,2-dimethylbutyric acid 

Downstream Products

• 1448600-50-7 C₁₂H₁₆BrN 
• 1448600-32-5 C₁₂H₁₄BrNO 
• 1448599-98-1 N-(2-bromophenyl)-N-((1-ethylcyclopropyl)methyl)-1,1,1-trifluoromethanesulfonamide 

Relevant academic research and scientific papers

Converting gem-dimethyl groups into cyclopropanes via Pd-catalyzed sequential C-H activation and radical cyclization

(Diagram presented) A novel route to the synthesis of cyclopropane derivatives is described. 1,1-Dimethyls in 2-(1,1-dimethylalkyl) dimethyloxazolines are first converted into 1,3-diiodide derivatives via Pd-catalyzed sequential C-H activation and then radically cyclized to provide 2-(1-alkylcylclopropyl)-dimethyloxazolines. The use of EtOAc as a solvent is crucial for the diiodination of the functionalized substrates.

PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS

The invention includes procedures for stereoselective β-arylation of carboxylic acids having a β-carbon atom. For example, stereoselective arylation procedures include the following reactions: (I)

Pd(II)-Catalyzed Enantioselective C(sp3)-H Arylation of Free Carboxylic Acids

A monoprotected aminoethyl amine chiral ligand based on an ethylenediamine backbone was developed to achieve Pd-catalyzed enantioselective C(sp3)-H arylation of cyclopropanecarboxylic and 2-aminoisobutyric acids without using exogenous directing groups. This new chiral catalyst affords new disconnection for preparing diverse chiral carboxylic acids from simple starting materials that are complementary to the various ring forming approaches.

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

Organic compounds

The present invention concerns prostaglandins having a cyclopropane ring in the 2,3 position.